Xingmei Yao

813 total citations
25 papers, 475 citations indexed

About

Xingmei Yao is a scholar working on Nephrology, Epidemiology and Molecular Biology. According to data from OpenAlex, Xingmei Yao has authored 25 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 9 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Xingmei Yao's work include Renal Diseases and Glomerulopathies (9 papers), Cervical Cancer and HPV Research (6 papers) and Chronic Kidney Disease and Diabetes (6 papers). Xingmei Yao is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Cervical Cancer and HPV Research (6 papers) and Chronic Kidney Disease and Diabetes (6 papers). Xingmei Yao collaborates with scholars based in China, United States and Pakistan. Xingmei Yao's co-authors include Yunman Wang, Bingbing Zhu, Ji Fang, Hengjiang Guo, Niansong Wang, Li Wang, Junliang Chen, Hao Wang, Yuqiang Chen and Xiaoxia Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Free Radical Biology and Medicine and International Journal of Cancer.

In The Last Decade

Xingmei Yao

21 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingmei Yao China 13 188 145 102 61 44 25 475
Cheng Ho Taiwan 15 236 1.3× 77 0.5× 47 0.5× 67 1.1× 87 2.0× 26 526
Vanessa Marchant Spain 12 244 1.3× 176 1.2× 72 0.7× 44 0.7× 97 2.2× 25 658
Shiva Kalantari Iran 15 232 1.2× 210 1.4× 62 0.6× 19 0.3× 47 1.1× 49 588
Florin L. Craciun United States 13 310 1.6× 92 0.6× 197 1.9× 99 1.6× 38 0.9× 13 705
Yongchun Ge China 9 131 0.7× 268 1.8× 57 0.6× 16 0.3× 57 1.3× 35 532
Mark A. Bryniarski United States 10 188 1.0× 76 0.5× 50 0.5× 34 0.6× 33 0.8× 14 411
Peichun Zhang China 10 191 1.0× 181 1.2× 51 0.5× 36 0.6× 18 0.4× 12 404
Abdelhadi M. Shebl Egypt 14 169 0.9× 36 0.2× 117 1.1× 41 0.7× 64 1.5× 40 524
Shanhong Lu China 13 254 1.4× 60 0.4× 37 0.4× 132 2.2× 60 1.4× 24 647
Shunmin Li China 11 137 0.7× 124 0.9× 38 0.4× 24 0.4× 30 0.7× 17 374

Countries citing papers authored by Xingmei Yao

Since Specialization
Citations

This map shows the geographic impact of Xingmei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingmei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingmei Yao more than expected).

Fields of papers citing papers by Xingmei Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingmei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingmei Yao. The network helps show where Xingmei Yao may publish in the future.

Co-authorship network of co-authors of Xingmei Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xingmei Yao. A scholar is included among the top collaborators of Xingmei Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingmei Yao. Xingmei Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yu, Qing Li, Ling Du, et al.. (2025). Epidemiologic evaluation of human papillomavirus type competition in unvaccinated women from Xiamen, China. Frontiers in Microbiology. 16. 1546166–1546166.
2.
Li, Siyu, Jiawen Wang, Ying Chen, et al.. (2025). Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice. Inflammation. 48(5). 3180–3193. 4 indexed citations
3.
Huang, Yanru, Yixi Zhou, Ye Shen, et al.. (2025). Splice‑site variant c.3531+1G>T in COL1A1 in a family with osteogenesis imperfecta. Molecular Medicine Reports. 32(2). 1–8.
4.
5.
Yao, Xingmei, Qing Li, Yu Chen, et al.. (2024). Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023. Frontiers in Public Health. 12. 1332696–1332696. 9 indexed citations
6.
Shen, Qian, Ji Fang, Hengjiang Guo, et al.. (2023). Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease. Free Radical Biology and Medicine. 203. 45–57. 60 indexed citations
7.
8.
Yao, Xingmei, et al.. (2022). Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy. Journal of Diabetes Research. 2022. 1–13. 12 indexed citations
9.
10.
Yu, Hui, Hongping Wang, Aili Cao, et al.. (2022). Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy. BMC Nephrology. 23(1). 41–41. 6 indexed citations
11.
Chen, Qi, Xiaohui Liu, Chunlan Zhuang, et al.. (2022). The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis. Emerging Microbes & Infections. 11(1). 793–803. 15 indexed citations
12.
Fang, Ji, Bingbing Zhu, Li Wang, et al.. (2021). Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy. Life Sciences. 269. 119068–119068. 67 indexed citations
13.
Chen, Qi, Hui Zhao, Xingmei Yao, et al.. (2020). Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages. Vaccine. 38(39). 6096–6102. 8 indexed citations
14.
Fang, Ji, Xingmei Yao, Miao Duan, et al.. (2020). ApoL1 induces kidney inflammation through RIG-I/NF-κB activation. Biochemical and Biophysical Research Communications. 527(2). 466–473. 19 indexed citations
15.
Guo, Hengjiang, Bingbing Zhu, Ji Fang, et al.. (2020). Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes. Biochemical and Biophysical Research Communications. 534. 450–456. 64 indexed citations
16.
Chen, Junliang, Li Wang, Xingmei Yao, et al.. (2019). Association of Urinary Plasminogen-Plasmin with Edema and Epithelial Sodium Channel Activation in Patients with Nephrotic Syndrome. American Journal of Nephrology. 50(2). 92–104. 15 indexed citations
17.
Wei, Feixue, Yingying Su, Xingmei Yao, et al.. (2019). Sex differences in the incidence and clearance of anal human papillomavirus infection among heterosexual men and women in Liuzhou, China: An observational cohort study. International Journal of Cancer. 145(3). 807–816. 14 indexed citations
18.
Yao, Xingmei, et al.. (2016). RNF213 gene polymorphisms and susceptibility of intracranial vascular stenosis disease: a meta-analysis. 24(10). 865–871. 1 indexed citations
19.
Yao, Xingmei, Yujun Liu, Yunman Wang, et al.. (2016). Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6. Molecular Medicine Reports. 13(6). 5149–5156. 36 indexed citations
20.
Chen, Yuqiang, Xiaoxia Wang, Xingmei Yao, et al.. (2011). MicroRNA-195 Promotes Apoptosis in Mouse Podocytes via Enhanced Caspase Activity Driven by BCL2 Insufficiency. American Journal of Nephrology. 34(6). 549–559. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng Ho Breakdown of academic impact, for papers by Vanessa Marchant Breakdown of academic impact, for papers by Shiva Kalantari Breakdown of academic impact, for papers by Florin L. Craciun Breakdown of academic impact, for papers by Yongchun Ge Breakdown of academic impact, for papers by Mark A. Bryniarski Breakdown of academic impact, for papers by Peichun Zhang Breakdown of academic impact, for papers by Abdelhadi M. Shebl Breakdown of academic impact, for papers by Shanhong Lu Breakdown of academic impact, for papers by Shunmin Li
Rankless by CCL
2026